Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Investigated for use/treatment in scar tissue.
- Mechanism
- Curator reviewed
AZX100 is a synthetic 24 amino acid peptide in the field of smooth muscle relaxation and fibrosis. Signaling pathways for actin-mediated smooth muscle relaxation converge by activating a protein called heat shock related protein 20 (HSP20). AZX-100 is a cell permeant peptide that mimics HSP20, bypassing the signaling pathways leading to smooth muscle relaxation. This mechanism of action is particularly important in certain patients, such as asthmatics with mutations in the β-receptor (β16 Arg/Arg genotype) or in some forms of vasospasm (such as subarachnoid hemorrhage induced vasospasm which leads to strokes). [Orthologic Corp. Website]
- Primary indication
- Investigated for use/treatment in scar tissue.Curator reviewed
- Code names
- AZX100
Resolves to
What you can answer from here — as of June 12, 2020
Which companies are running trials of AZX-100, in which indications and phases, and which of those programs are still active?